Lymphopenia, which is a prominent feature of COVID-19 and a hallmark of severe infection, distinguished LVS from SVS or asymptomatic individuals (Fig. S8A, B), as exemplified for the proportion of B lymphocytes among total CD45+ leukocytes after 20 days of symptoms. This evidence concerns the gene PTPRC and COVID-19.